Epidemiology and Clinical Profile of Takotsubo Cardiomyopathy

  • Sharkey Scott W.
    Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital
  • Maron Barry J.
    Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital the Hypertrophic Cardiomyopathy Center

この論文をさがす

抄録

First described in Japan over 2 decades ago, takotsubo cardiomyopathy (TTC) has emerged as a unique cardiomyopathy with world-wide recognition, mimicking acute coronary syndrome. In early TTC experience, typical patients were older women, with a triggering emotional event, ST-segment elevation, and apical ballooning left ventricular (LV) contraction pattern. However, TTC is now more heterogeneous, occurring in males and younger individuals, without ST-segment elevation, as a spontaneous event in the absence of a trigger, and with diverse LV contraction patterns. Furthermore, TTC is more common than initially thought, now constituting 10% of women with suspected acute coronary syndrome. TTC is also associated with a broader range of psychological or physical triggers, including presentation during outpatient medical evaluations or hospitalization for acute illness. Although TTC has been considered a benign condition, it now carries a small but important risk for adverse outcomes, including cardiac arrest in 5%. Hemodynamic instability requiring intervention with vasopressor drugs or intra-aortic balloon pump is necessary in 15% and in-hospital mortality is approximately 5%, largely because of refractory cardiogenic shock or irreversible major comorbid conditions. Although complete cardiac recovery usually occurs rapidly, post-hospital survival may be less than the general population of similar age, largely because of concomitant illnesses. TTC may reoccur in up to 10% of patients, but β-blocking drugs are not absolutely preventive for initial or subsequent events. (Circ J2014;78:2119–2128)

収録刊行物

  • Circulation Journal

    Circulation Journal 78 (9), 2119-2128, 2014

    一般社団法人 日本循環器学会

被引用文献 (12)*注記

もっと見る

参考文献 (77)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ